C M Capitini

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation
    Christian M Capitini
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 31:142-4. 2009
  2. ncbi Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect
    Christian M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 113:5002-9. 2009
  3. ncbi Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting
    Christian M Capitini
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 31:227-44. 2009
  4. ncbi Modulating T-cell homeostasis with IL-7: preclinical and clinical studies
    C M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Intern Med 266:141-53. 2009
  5. ncbi Immune-based therapeutics for pediatric cancer
    Christian M Capitini
    National Cancer Institute, National Institutes of Health, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, MSC 1104, Bethesda, MD 20892, USA
    Expert Opin Biol Ther 10:163-78. 2010
  6. ncbi Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination
    Christian M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 17:790-9. 2011
  7. ncbi Highlights of the second international conference on "Immunotherapy in Pediatric Oncology"
    Christian M Capitini
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Pediatr Hematol Oncol 28:459-60. 2011
  8. ncbi Immunotherapy of childhood cancer: from biologic understanding to clinical application
    Alan S Wayne
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1 3750, 9000 Rockville Pike, MSC 1104, Bethesda, MD 20892 1104, USA
    Curr Opin Pediatr 22:2-11. 2010
  9. ncbi Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
    C Y Koh
    Laboratory of Leukocyte Biology, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD, USA
    Blood 97:3132-7. 2001

Detail Information

Publications9

  1. ncbi Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation
    Christian M Capitini
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 31:142-4. 2009
    ..Further clinical trials are needed to evaluate the role for allogeneic SCT for this disease...
  2. ncbi Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect
    Christian M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 113:5002-9. 2009
    ....
  3. ncbi Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting
    Christian M Capitini
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 31:227-44. 2009
    ..The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies...
  4. ncbi Modulating T-cell homeostasis with IL-7: preclinical and clinical studies
    C M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Intern Med 266:141-53. 2009
    ..This review will address current understanding of IL-7 biology, review recent clinical experiences and discuss potential future clinical applications of IL-7, or IL-7 blockade, in the setting of disease...
  5. ncbi Immune-based therapeutics for pediatric cancer
    Christian M Capitini
    National Cancer Institute, National Institutes of Health, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, MSC 1104, Bethesda, MD 20892, USA
    Expert Opin Biol Ther 10:163-78. 2010
    ..Elucidation of the principles of tumor biology and the development of novel laboratory technologies over the last decade have led to substantial progress in bringing immunotherapies to the bedside...
  6. ncbi Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination
    Christian M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 17:790-9. 2011
    ..Importantly, the attenuation of GVHD by ECP-treated splenocytes permits donor lymphocyte infusion-dependent responses to DC vaccines after allo-BMT...
  7. ncbi Highlights of the second international conference on "Immunotherapy in Pediatric Oncology"
    Christian M Capitini
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Pediatr Hematol Oncol 28:459-60. 2011
    ..The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies...
  8. ncbi Immunotherapy of childhood cancer: from biologic understanding to clinical application
    Alan S Wayne
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1 3750, 9000 Rockville Pike, MSC 1104, Bethesda, MD 20892 1104, USA
    Curr Opin Pediatr 22:2-11. 2010
    ..This review summarizes the biologic basis of cancer immunotherapy and highlights recent examples of progress in the application of novel humoral and cellular immunotherapies to children and adolescents with malignancy...
  9. ncbi Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
    C Y Koh
    Laboratory of Leukocyte Biology, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD, USA
    Blood 97:3132-7. 2001
    ..Therefore, strategies to block inhibitory receptors may be of potential use in increasing the efficacy of immunotherapy. (Blood. 2001;97:3132-3137)..